This paper, written by an expert panel on behalf of the International Myeloma Working Group, outlines the state of knowledge of treatment-induced peripheral neuropathy in myeloma patients and the various management practices, providing recommendations for the optimal management of patients who develop peripheral neuropathy during treatment.
This article, written by the International Myeloma Working Group, reviews the evidence and provides a consensus on the diagnostic criteria, response criteria and treatment recommendations for primary plasma cell leukemia.
This article, written by an expert panel on behalf of the International Myeloma Working Group, discusses a variety of issues regarding stem cell collection and transplantation in myeloma and the role of plerixafor, providing a summary of the deliberations and conclusions.
This paper, written by an expert panel on behalf of the International Myeloma Working Group, provides consensus guidelines for the use of the serum free light chain assay in the diagnosis and management of clonal plasma cell disorders.
This paper, written by an expert panel on behalf of the International Myeloma Working Group, outlines consensus recommendations for risk stratification for clinical and clinical trial use.
This paper, written by an expert panel of the International Myeloma Working Group, examines the impact of novel treatments on stem cell collection in myeloma patients. It summarises the available evidence and makes recommendations to address identified issues.